Page last updated: 2024-08-25

methotrexate and Obesity

methotrexate has been researched along with Obesity in 59 studies

Research

Studies (59)

TimeframeStudies, this research(%)All Research%
pre-19908 (13.56)18.7374
1990's7 (11.86)18.2507
2000's9 (15.25)29.6817
2010's28 (47.46)24.3611
2020's7 (11.86)2.80

Authors

AuthorsStudies
Arias-de la Rosa, I; Barbarroja, N; Collantes-Estévez, E; Cordoba, J; Cuesta-López, L; Escudero-Contreras, A; Gahete, MD; González, A; Leiva-Cepas, F; López-Pedrera, C; Lucendo, AJ; Navarro, P; Ortega, R; Pérez-Pampin, E; Pérez-Sánchez, C; Ruiz-Ponce, M1
Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ1
Debacker, KC; Derstine, B; Pai, MP; Su, GL; Sullivan, J; Wang, SC1
Arlegui, H; Assan, F; Bachelez, H; Beneton, N; Beylot-Barry, M; Chosidow, O; Dupuy, A; Giboin, C; Joly, P; Jullien, D; Mahé, E; Paul, C; Richard, MA; Sbidian, E; Tubach, F; Viguier, M1
Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K1
Bergstra, SA; Dey, M; Goodson, NJ; Landewe, RB; Moots, RJ; Zhao, SS1
Eaton, P; Rudyk, O1
Alazawi, W; Cho, W; Shetty, A; Syn, WK1
Bonifati, C; Graceffa, D; Lora, V1
Kaeley, GS; Kalabic, J; MacCarter, DK; Pangan, AL; Ranganath, VK; Wang, X1
Chiricozzi, A; Girolomoni, G; Gisondi, P1
Baran, A; Flisiak, I; Kiluk, P; Maciaszek, M; Świderska, M1
Di Minno, MN; Iervolino, S; Lupoli, R; Peluso, R; Russolillo, A; Scarpa, R1
Calhau, C; Cunha, A; Faria, A; Keating, E; Marques, C; Meireles, M; Monteiro, R; Pestana, D; Teixeira, D1
Pais, R; Ratziu, V; Rusu, E1
Gerdes, S; Mrowietz, U; Steinz, K1
Alfredsson, L; Bengtsson, C; Källberg, H; Klareskog, L; Saevarsdottir, S; Sandberg, ME; Wesley, A1
Kirby, B; Ryan, C1
Lopez-Ferrer, A; Puig, L; Spertino, J; Vilarrasa, E1
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Moulder, J; Ramírez, LA1
Philipsen, P; Skiveren, J; Therming, G1
Prussick, R; Unnebrink, K; Valdecantos, WC1
Avsar, E; Ergun, T; Ozgen, Z; Seckin, D; Tula, E1
Amadori, D; Antonucci, G; Biglia, N; Bruzzi, P; Farolfi, A; Gennari, A; Gianni, L; Maltoni, R; Mangia, A; Nanni, O; Paradiso, A; Rocca, A; Scarpi, E; Tienghi, A1
Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M1
Francès, C1
Hawks, RG; Meza, JL; Post-White, JE; Sacks, N; Seibel, NL; Smith, LM; Withycombe, JS1
Dann, F; Gottlieb, AB1
Bulai Livideanu, C; Lahfa, M; Mazereeuw-Hautier, J; Paul, C1
Aronow, BJ; Gibson, G; Kim, J; Mason, E; Matigian, N; Nones, K; Tronc, G; Wells, C; Wolfinger, RD1
Ferrazzi, A; Girolomoni, G; Gisondi, P1
Balwierz, W; Bik-Multanowski, M; Galicka-Latala, D; Gozdzik, J; Pietrzyk, JJ; Strojny, W; Surmiak, M; Szymon, S1
Del Giglio, M; Girolomoni, G; Gisondi, P; Tessari, G1
Acedo, SC; Carvalho, Pde O; DeOliveira, CC; Gambero, A; Gotardo, EM; Pedrazzoli, J; Rocha, T1
Menter, A; Ryan, C1
Abritta, G; Cravero, A; Enriquez, N; Martínez Artola, Y; Ortiz, V; Palermo, C; Poncino, D; Rosenberg, S; Santiago García, D; Saturansky, E1
Forien, M; Mahé, E; Marchal, A; Sigal, ML; Sin, C1
Barthelemy, H; Beauchet, A; Begon, E; Boyé, T; Bravard, P; Chaby, G; Descamps, V; Estève, E; Girard, C; Maccari, F; Mahé, E; Maillard, H; Quiles-Tsimaratos, N; Reguiai, Z; Schmutz, JL; Sigal, ML1
Hongeng, S; Hudson, MM; Pui, CH; Razzouk, BI; Rose, SR; Smeltzer, MP; Wallace, D; Zacher, M1
Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS1
Chabrun, E; Chanteloup, E; Couzigou, P; de Lédinghen, V; Laharie, D; Terrebonne, E; Vergniol, J1
Hicke, A; Sońta-Jakimczyk, D; Tomaszewska, R; Wieczorek, M1
Colwell, SJ; Eastwood, BJ; Malatjalian, DA; Ross, JB; Williams, CN1
Bernáldez-Ríos, R; Espinoza-Hernández, L; Fajardo-Gutíerrez, A; Martínez-García, MC; Mejía-Arangure, JM; Rodríguez-Zepeda, MC1
Donaldson, M; Gibson, B; Ralston, JM; Reilly, JJ; Ventham, JC1
Blomqvist, C; Joensuu, H; Poikonen, P1
Bjarnason, GA; Franssen, E; Madarnas, Y; Sawka, CA1
Lewis, V; Piatkowski, J; Rydholm, N; Sauer, M; Steiner, M1
Russo, A; Schilirò, G; Sciotto, A; Vigo, R1
Nyfors, A; Poulsen, H2
Beattie, CW; Das Gupta, TK; Mehta, RR1
Cera, PJ; Mangan, TF; Newman, ED; Phillips, CA1
Eldridge, RM; Fleming, RA; Johnson, CE; Stewart, CF1
Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC1
Akerman, M; Berge, G; Lundquist, A; Rorsman, H1
Bergfeld, WF; Hawk, WA; Owens, FJ; Roenigk, HH; St Jacques, R1
Carnelli, V; Masera, G1

Reviews

9 review(s) available for methotrexate and Obesity

ArticleYear
Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.
    The American journal of the medical sciences, 2017, Volume: 354, Issue:2

    Topics: Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Dermatologic Agents; Diabetes Mellitus; Humans; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors

2017
The pharmacological management of patients with comorbid psoriasis and obesity.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:7

    Topics: Adipokines; Antibodies, Monoclonal; Cytokines; Dermatologic Agents; Humans; Immunosuppressive Agents; Methotrexate; Obesity; Phototherapy; Psoriasis

2019
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.
    Clinics in liver disease, 2014, Volume: 18, Issue:1

    Topics: Acetaminophen; Anesthetics; Animals; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Insulin Resistance; Male; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Risk Factors; Trans-Activators; Viral Regulatory and Accessory Proteins

2014
Psoriasis: to treat or to manage?
    Experimental dermatology, 2014, Volume: 23, Issue:10

    Topics: Antibodies, Anti-Idiotypic; Biological Products; Comorbidity; Humans; Immunosuppressive Agents; Methotrexate; Obesity; Psoriasis; Risk Factors; Treatment Outcome

2014
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Dermatologic clinics, 2015, Volume: 33, Issue:1

    Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab

2015
Comorbidities in patients with psoriasis.
    The American journal of medicine, 2009, Volume: 122, Issue:12

    Topics: Arthritis, Psoriatic; Cardiovascular Diseases; Dermatologic Agents; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Methotrexate; Neoplasms; Obesity; Psoriasis

2009
Metabolic comorbidities and psoriasis.
    Acta dermatovenerologica Croatica : ADC, 2010, Volume: 18, Issue:4

    Topics: Arthritis, Psoriatic; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Insulin Resistance; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Psoriasis; Risk Factors

2010
Psoriasis and cardiovascular disorders.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2012, Volume: 147, Issue:2

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cardiotonic Agents; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Humans; Inflammation; Interleukin-12 Subunit p40; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab

2012
[The liver and methotrexate].
    Gastroenterologie clinique et biologique, 2008, Volume: 32, Issue:2

    Topics: Alcohol Drinking; Diabetes Complications; Drug Monitoring; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Methotrexate; Obesity; Risk Factors

2008

Trials

6 trial(s) available for methotrexate and Obesity

ArticleYear
Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate.
    The Journal of rheumatology, 2018, Volume: 45, Issue:12

    Topics: Adalimumab; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Obesity; Synovial Membrane; Treatment Outcome

2018
Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:6

    Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Caloric Restriction; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Middle Aged; Obesity; Overweight; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha

2014
Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:8

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Body Mass Index; Dermatologic Agents; Female; Humans; Ideal Body Weight; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome

2015
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
    Breast cancer research and treatment, 2016, Volume: 159, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Obesity; Prognosis; Survival Analysis; Treatment Outcome; Young Adult

2016
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study.
    Dermatology (Basel, Switzerland), 2012, Volume: 224, Issue:1

    Topics: Adult; Aged; Body Mass Index; Dermatologic Agents; Diet, Reducing; Female; Humans; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome; Weight Loss

2012
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Obesity; Prednisone; Prognosis; Random Allocation; Receptors, Estrogen; Risk; Tamoxifen

1985

Other Studies

44 other study(ies) available for methotrexate and Obesity

ArticleYear
Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis.
    European journal of internal medicine, 2023, Volume: 118

    Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Cross-Sectional Studies; Humans; Inflammation; Liver Diseases; Longitudinal Studies; Methotrexate; Mice; Obesity; Peptides, Cyclic

2023
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
    Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids

2020
Comparison of Body Size, Morphomics, and Kidney Function as Covariates of High-Dose Methotrexate Clearance in Obese Adults with Primary Central Nervous System Lymphoma.
    Pharmacotherapy, 2020, Volume: 40, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Body Size; Central Nervous System Neoplasms; Female; Humans; Kidney; Lymphoma; Male; Medical Records; Methotrexate; Middle Aged; Obesity; Retrospective Studies

2020
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq.
    Dermatology (Basel, Switzerland), 2021, Volume: 237, Issue:3

    Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Biological Therapy; Body Mass Index; Cohort Studies; Dermatologic Agents; Etanercept; Female; France; Humans; Infliximab; Male; Methotrexate; Middle Aged; Obesity; Patient Selection; Psoriasis; Ustekinumab

2021
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
    CNS drugs, 2021, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult

2021
The association between increased body mass index and response to conventional synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: results from the METEOR database.
    Rheumatology (Oxford, England), 2022, 02-02, Volume: 61, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Databases as Topic; Female; Humans; Linear Models; Logistic Models; Male; Methotrexate; Middle Aged; Obesity; Patient Acuity; Treatment Outcome

2022
Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.
    Free radical biology & medicine, 2017, Volume: 110

    Topics: Animals; Aorta; Carmustine; Cattle; Cyclic GMP-Dependent Protein Kinase Type I; Diet, High-Fat; Endothelial Cells; Gene Expression Regulation; Glucagon; Hypertension; Leptin; Methotrexate; Mice; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Obesity; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Resistin; Signal Transduction; Sugar Acids; Uncoupling Agents

2017
Doubling golimumab doses did not improve skin disease in two obese patients with psoriatic arthritis.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2017, Volume: 152, Issue:6

    Topics: Adult; Antibodies, Monoclonal; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Drug Substitution; Humans; Male; Methotrexate; Middle Aged; Obesity; Treatment Failure; Ustekinumab

2017
Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasis.
    The Journal of dermatological treatment, 2020, Volume: 31, Issue:5

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acitretin; Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Humans; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Risk Factors; Young Adult

2020
Methotrexate enhances 3T3-L1 adipocytes hypertrophy.
    Cell biology and toxicology, 2013, Volume: 29, Issue:4

    Topics: 3T3 Cells; Adipocytes; Adipogenesis; Animals; Arthritis, Rheumatoid; Biological Transport; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Folic Acid Antagonists; Glucose; Insulin; Lipid Metabolism; Metabolic Syndrome; Methotrexate; Mice; Obesity

2013
Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:11

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Early Diagnosis; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Obesity; Overweight; Pain; Pain Measurement; Prognosis; Registries; Remission Induction; Severity of Illness Index; Sweden; Treatment Outcome

2014
Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Cohort Studies; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infliximab; Infusion Pumps; Kaplan-Meier Estimate; Longitudinal Studies; Male; Methotrexate; Middle Aged; Models, Statistical; Obesity; Psoriasis; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult

2014
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Obesity; Overweight; Pregnancy; Prognosis; Remission Induction; Vincristine; Young Adult

2015
Patients with psoriasis have insufficient knowledge of their risk of atherothrombotic disease and metabolic syndrome.
    Clinical and experimental dermatology, 2015, Volume: 40, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Psoriatic; Atherosclerosis; Depressive Disorder; Diabetes Mellitus; Female; Health Knowledge, Attitudes, Practice; Humans; Hypertension; Immunosuppressive Agents; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Obesity; Patient Education as Topic; Psoriasis; Risk Factors; Thrombosis; Young Adult

2015
Psoriasis and the liver: problems, causes and course.
    The Australasian journal of dermatology, 2017, Volume: 58, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Child; Dermatologic Agents; Diabetes Complications; Female; Humans; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Young Adult

2017
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    International journal of dermatology, 2017, Volume: 56, Issue:4

    Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index

2017
[What's new in internal medicine?].
    Annales de dermatologie et de venereologie, 2008, Volume: 135 Suppl 7

    Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Bacteriophages; Body Mass Index; Diabetes Complications; Drug Therapy, Combination; Humans; Hydroxychloroquine; Hypereosinophilic Syndrome; Hypertension; Immunosuppressive Agents; Internal Medicine; Methotrexate; Mimiviridae; Obesity; Risk Factors; Treatment Outcome; Venous Thromboembolism

2008
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Child, Preschool; Cranial Irradiation; Cytarabine; Daunorubicin; Ethnicity; Female; Gastrointestinal Diseases; Glucose Intolerance; Humans; Incidence; Male; Methotrexate; Obesity; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Vincristine; Weight Gain; Weight Loss; Young Adult

2009
Efficacy of ustekinumab in palmoplantar psoriasis.
    Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Female; Humans; Male; Methotrexate; Obesity; Psoriasis; Smoking; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab; Vitamin D

2010
Maternal influences on the transmission of leukocyte gene expression profiles in population samples from Brisbane, Australia.
    PloS one, 2010, Dec-31, Volume: 5, Issue:12

    Topics: Australia; Body Mass Index; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes, Gestational; False Positive Reactions; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Leukocytes; Maternal Exposure; Methotrexate; Obesity; Pregnancy; Pregnancy Complications; Vitamin E

2010
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
    Journal of genetics, 2011, Volume: 90, Issue:2

    Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Genetic Association Studies; Homozygote; Humans; Male; Methotrexate; Obesity; Odds Ratio; Overweight; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proteins; Radiotherapy; Risk Factors; Survivors; Thioguanine; Vincristine; Young Adult

2011
Effects of methotrexate on inflammatory alterations induced by obesity: an in vivo and in vitro study.
    Molecular and cellular endocrinology, 2012, Sep-25, Volume: 361, Issue:1-2

    Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Adiposity; Animals; Body Weight; Coculture Techniques; Cytokines; Diet, High-Fat; Epididymis; Inflammation; JNK Mitogen-Activated Protein Kinases; Lipolysis; Macrophages; Male; Methotrexate; Mice; Nitric Oxide Synthase Type II; Obesity; Phosphorylation

2012
[Liver diseases in rheumatoid and psoriatic arthritis].
    Acta gastroenterologica Latinoamericana, 2012, Volume: 42, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Cohort Studies; Cross-Sectional Studies; Fatty Liver; Female; Humans; Male; Methotrexate; Middle Aged; Obesity; Risk Factors

2012
[Body-weight changes in psoriatic patients on systemic treatment].
    Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:10

    Topics: Adult; Aged; Antibodies, Monoclonal; Arthritis, Psoriatic; Body Weight; Comorbidity; Dermatologic Agents; Female; Humans; Infliximab; Long-Term Care; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Tumor Necrosis Factor-alpha

2012
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Diet; Dyslipidemias; Female; Humans; Hypertension; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Smoking; Weight Gain

2014
Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-01, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Body Mass Index; Child; Child, Preschool; Cranial Irradiation; Female; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies

2007
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
    Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:5

    Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha

2008
[Obesity as the first manifestation of central nervous system involvement in acute lymphoblastic leukemia].
    Pediatria polska, 1996, Volume: 71, Issue:8

    Topics: Antineoplastic Agents; Body Mass Index; Child; Combined Modality Therapy; Cytarabine; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Recurrence

1996
Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 1996, Volume: 10, Issue:6

    Topics: Adolescent; Adult; Aged; Alcohol Drinking; Biopsy; Child; Diabetes Complications; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Liver; Liver Cirrhosis; Male; Methotrexate; Middle Aged; Nova Scotia; Obesity; Psoriasis; Retrospective Studies; Risk Factors; Time Factors

1996
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body Constitution; Child; Child, Preschool; Cohort Studies; Cytarabine; Drug Administration Schedule; Energy Metabolism; Epirubicin; Female; Gastrointestinal Diseases; Hospitals, General; Hospitals, Pediatric; Humans; Infant; Male; Mercaptopurine; Methotrexate; Nutrition Disorders; Nutritional Status; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk; Skinfold Thickness; Vincristine

1997
Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia.
    Pediatric research, 1998, Volume: 44, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Energy Metabolism; Female; Humans; Male; Mercaptopurine; Methotrexate; Obesity; Physical Exertion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Reference Values; Survivors; Vincristine; Weight Gain

1998
Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area.
    Acta oncologica (Stockholm, Sweden), 2001, Volume: 40, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Constitution; Body Mass Index; Body Surface Area; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Leukocyte Count; Leukopenia; Methotrexate; Middle Aged; Obesity

2001
Are medical oncologists biased in their treatment of the large woman with breast cancer?
    Breast cancer research and treatment, 2001, Volume: 66, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Attitude of Health Personnel; Body Mass Index; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Medical Oncology; Methotrexate; Middle Aged; Obesity; Ontario; Practice Patterns, Physicians'; Prejudice; Retrospective Studies

2001
Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 2002, Volume: 19, Issue:2

    Topics: Adolescent; Antimetabolites, Antineoplastic; Humans; Kidney Diseases; Leucovorin; Male; Methotrexate; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioisotope Renography

2002
Insulin and growth hormone secretion in a leukaemic girl with hypothalamic syndrome.
    Acta paediatrica Scandinavica, 1977, Volume: 66, Issue:2

    Topics: Arginine; Child; Female; Growth Hormone; Humans; Insulin; Insulin Secretion; Leukemia, Lymphoid; Methotrexate; Obesity; Triamcinolone; Vincristine

1977
Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non-methotrexate treated patients.
    Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1976, Volume: 84, Issue:3

    Topics: Adult; Age Factors; Aged; Alcohol Drinking; Aspartate Aminotransferases; Body Weight; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis

1976
Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1976, Volume: 84, Issue:3

    Topics: Adult; Age Factors; Aged; Alcohol Drinking; Aspartate Aminotransferases; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis

1976
Endocrine profile in breast cancer patients receiving chemotherapy.
    Breast cancer research and treatment, 1992, Volume: 20, Issue:2

    Topics: Adult; Age Factors; Amenorrhea; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estradiol; Estrone; Female; Fluorouracil; Hormones; Humans; Luteinizing Hormone; Methotrexate; Middle Aged; Obesity; Prolactin

1992
Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    The Journal of rheumatology, 1992, Volume: 19, Issue:2

    Topics: Aged; Arthritis, Rheumatoid; Biopsy; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Humans; Incidence; Liver; Liver Cirrhosis; Liver Diseases; Methotrexate; Middle Aged; Obesity; Pulmonary Fibrosis

1992
Disposition of high-dose methotrexate in an obese cancer patient.
    Cancer, 1991, Sep-15, Volume: 68, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Half-Life; Humans; Leucovorin; Methotrexate; Obesity; Osteosarcoma; Tibia; Vincristine

1991
Psoriasis-liver-methotrexate interactions.
    Archives of dermatology, 1973, Volume: 108, Issue:1

    Topics: Administration, Oral; Adrenal Cortex Hormones; Age Factors; Alanine Transaminase; Alcohol Drinking; Alkaline Phosphatase; Aspartate Aminotransferases; Biopsy; Diabetes Complications; Female; Humans; Liver; Liver Cirrhosis; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Sex Factors; Sulfobromophthalein; Time Factors

1973
Liver biopsy in psoriasis.
    The British journal of dermatology, 1970, Volume: 82, Issue:3

    Topics: Adult; Aged; Alcoholism; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Transaminases

1970
Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Archives of dermatology, 1971, Volume: 103, Issue:3

    Topics: Adolescent; Adult; Aged; Alcoholism; Biopsy; Chemical and Drug Induced Liver Injury; Diabetes Complications; Female; Follow-Up Studies; Humans; Liver; Liver Function Tests; Male; Methotrexate; Middle Aged; Obesity; Prospective Studies; Psoriasis; Retrospective Studies

1971
[Complications in the central nervous system in acute leukemia in children. Clinical contribution].
    Minerva pediatrica, 1969, Feb-25, Volume: 21, Issue:8

    Topics: Central Nervous System Diseases; Humans; Leukemia; Methotrexate; Neurologic Manifestations; Obesity

1969